Quantapore, Inc.
PrivateLast Round
Series 3
Jul 18, 2018
Total Funding Raised
$15.55M
Company Overview
Quantapore, Inc. operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series 3 round in July 2018.
Quantapore, Inc. is a biotechnology company that develops nanopore-based nucleic acid sequencing technology designed to provide rapid, affordable, and high-throughput genomic analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quantapore, Inc. Comparables
Compare Quantapore, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Element Biosciences | 86% | |
| Swan Genomics | 84% | |
| Axbio | 83% |
For institutional investors. Book with your work email.
Quantapore, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series 3 | Jul 18, 2018 | ||||
| Series C | Sep 27, 2016 |
For institutional investors. Book with your work email.
Quantapore, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series 3 |
| Baidu Ventures | Series 3 |
| Northern Light Venture Capital | Series 3 |
| Foothill Ventures | Series 3 |
| Cloudstone Capital | Series 3 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2018
$16M round led by Northern Light Venture Capital.
For institutional investors. Book with your work email.
Quantapore, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quantapore, Inc.'s valuation, stock price, and market status.
Is Quantapore, Inc. a public or private company?
Quantapore, Inc. is a private company.
What is the current stock price of Quantapore, Inc.?
Quantapore, Inc. is a private company, so its shares have no public market price. Caplight tracks Quantapore, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quantapore, Inc. worth (valuation)?
Valuation information for Quantapore, Inc. is not publicly available.
Can I buy Quantapore, Inc. stock?
Quantapore, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quantapore, Inc.'s last funding round?
Quantapore, Inc.'s most recent funding round was Series 3 on July 18, 2018.
Who are the main investors in Quantapore, Inc.?
Key investors in Quantapore, Inc. include Northern Light Venture Capital.
Will Quantapore, Inc. IPO soon?
No public IPO plans have been announced for Quantapore, Inc..
How can I track Quantapore, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Quantapore, Inc.'s shares on secondary markets.